|
State of California -Health and Welfare Agency
<br />(Continued)
<br />Depart hent of Health Services
<br />Page 3 of 7 pages
<br />License Number. 1812-39
<br />F. Group 6 Brachytherapy and Ophthalmic treatments utilizing sealed or solid sources manufactured,
<br />labeled, packaged, and distributed in accordance with a specific license issued pursuant to Title
<br />10, Code of Federal Regulations, Part 32.74, or a specific license issued by an agreement state
<br />pursuant to equivalent state regulations (except for sources manufactured prior to August 16,
<br />1974).
<br />L-5. Brachytherapy
<br />6. Applicator
<br />G. Group 9 Nonhuman use: Marker and calibration sources.
<br />LICENSE CONDITIONS
<br />10. Radioactive material shall be used only at the following locations:
<br />(a) 525 West Acacia Street, Stockton, CA
<br />11. This license is subject to an annual fee for sources of radioactive material authorized to be possessed at any
<br />one time as specified in Item 6, 7, 8 and 9 of this license. The annual fee for this license is required by and
<br />computed in accordance with Title 17, California Code of Regulations, Sections 30230-30232 and is also
<br />subject to an annual cost -of -living adjustment pursuant to Section 113 of the California Health and Safety
<br />Code.
<br />12. The individuals named below are authorized the specific uses of radioactive material described in Items .6, 7,
<br />8 and 9 of this license as follows:
<br />(a)
<br />Anil K. Sain, NLD.
<br />Groups
<br />1, 2, 3, 4, and 9
<br />(b)
<br />Michael G. Khoury, NLD.
<br />Groups
<br />1, 2, 3, and 9
<br />(c)
<br />Michael D. Reitz, NLD.
<br />Groups
<br />1, 2, 3, 4 (except colloidal P-32), 5, and 9
<br />(d)
<br />James D. Rooke, NLD.
<br />Groups
<br />4 (Thyroid therapy only) and 5
<br />(e)
<br />John B. Irish, MD.
<br />Group
<br />6 (Strontium 90 only)
<br />(f)
<br />Jerome I. Bookin, MD.
<br />Group
<br />6 (Strontium 90 only)
<br />(g)
<br />Chull S. Song, M.D.
<br />Groups
<br />1, 2, 3, 6 (Strontium 90 only), and 9
<br />(h)
<br />Edward C. Greenleaf, MD.
<br />Group
<br />6
<br />(i)
<br />Bolar Rama Rao, MD.
<br />Groups
<br />1, 2, 3, 4, 5, and 9
<br />0)
<br />Dr. Dave Bernard, MD.
<br />Groups
<br />1, 2, 3, 4, 5, and 9
<br />
|